Rosaceiform dermatitis associated with topical tacrolimus treatment
- PMID: 20466178
- DOI: 10.1016/j.jaad.2009.01.029
Rosaceiform dermatitis associated with topical tacrolimus treatment
Abstract
We describe herein 3 patients who developed rosacea-like dermatitis eruptions while using 0.03% or 0.1% tacrolimus ointment for facial dermatitis. Skin biopsy specimens showed telangiectasia and noncaseating epithelioid granulomatous tissue formation in the papillary to mid dermis. Continuous topical use of immunomodulators such as tacrolimus or pimecrolimus should be regarded as a potential cause of rosaceiform dermatitis, although many cases have not been reported.
Copyright 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
